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ABSTRACT The technique of small angle neutron scattering has been used to determine the
molecular shape, the volume, and the molecular weight of pooled human transferrin in an
aqueous solution isotonic with blood. Analysis of the measurements assuming a spheroidal
molecular shape indicates that an oblate spheroid with semi-axes of length 46.6 ± 1.4, 46.6 ±
1.4, and 15.8 ± 3.8A, and a molecular volume of (144 ± 45) x 103 A3 is the best simple
approximation to the shape of the transferrin molecule. The radius of gyration, Rg, determined
from a Guinier plot is 30.25 ± 0.49 A, in agreement with Rg calculated for the oblate
spheroidal shape. The molecular weight is determined to be (75 ± 5) x 103. The shape-
independent molecular volume is found to be (98 ± 10) x 103A3. The difference in the two
volumes suggests that transferrin is not a uniform spheroid but may have a more complex
shape.
INTRODUCTION
Transferrin is a glycoprotein whose general function is to transport iron in the blood. The
exact nature of the iron exchange mechanism between transferrin and other molecules such as
hemoglobin is not known in detail, but a knowledge of molecular characteristics of transferrin,
such as shape and volume, would help in understanding how these exchange processes occur.
The detailed molecular structure can only be determined by diffraction measurements on the
molecule in crystalized form. However, if deductions made on the basis of such a structure
determination are to have biological relevance, it is crucial to know if the molecular
characteristics derived in this manner are compatible with those of the molecule in its natural
state (i.e., in blood). For example, the detailed structure of crystallized human hemoglobin
has been determined by x-ray diffraction measurements (1), while the molecular characteris-
tics of hemoglobin in aqueous solution were determined by small angle scattering (see
reference 2 and references therein). The compatibility of these two determinations validates
the deductions about the biological functions of this blood protein which were drawn from a
knowledge of its detailed structure (see for example Perutz [3]).
The detailed structure of crystalized transferrin has not yet been determined, but such
measurements are in progress (4). In the present paper we report small angle neutron
scattering measurements (SANS) on human transferrin in an aqueous solution simulating
that of blood. The results are analyzed to provide information on the size and shape of the
transferrin molecule in this "natural" environment. There has been disagreement about the
correct molecular weight of transferrin (5, 6, 7), and the present measurements provide a
further determination of this quantity. For purposes of calibration, some measurements have
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also been made on hemoglobin, and the molecular shape of this molecule determined from our
analysis is compared with the results of Schelten et al. (2).
MATERIALS AND METHODS
Specimens
The specimens were made from crystalized, pooled human transferrin purchased from Sigma Chemical
Co., St. Louis, Mo., and from Miles Laboratories Inc., Elkhart, Ind. Despite the fact that 17 transferrin
variants are known (8), the heterogeneity expected in pooled specimens is small, since the C variant is by
far the dominant one. The specimen from Sigma was a stock item while that from Miles was a special
preparation and was utilized within 2 wk of crystalization. Both specimens were essentially iron-free.
The Sigma samples were examined by dissolving aliquots in Tris-glycine buffer, pH 8.3, and performing
gel electrophoresis on 7.5% acrylamide stained with amido-black. Only one major dark-staining band
was observed. Two minor bands with weak mobilities were also present. A similar analysis was not
performed on the Miles samples but within experimental error they gave the same small angle scattering
results as the Sigma samples. There is a slow exchange of deuterons with hydrogen when hemoglobin is
dissolved in D20 (2). To ensure that such exchange was completed before measurements were made on
the transferrin solutions, all solutions were prepared at least 24 h before their use.
The solvent used in all measurements was Ringer's salt solution. It consisted of 9 g NaCl, 0.42 g KCI
and 0.25 g CaC12 with sufficient water added to make up 1 liter of solution. These salt concentrations
correspond to 0.154, 0.006, and 0.002 M, respectively, where M is the molecular weight per liter. The
solution had a pH of 6.7 and upon addition of transferrin increased to values typically around 7.3.
Ringer's solution was used to ensure that the osmotic environment of the transferrin molecules was
similar to that of blood.
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FIGURE I Small angle neutron scattering from transferrin (c = 4.11 g/liter) in pure D20 Ringer's
solution. The points represent the experimental data and the line is the best fit assuming an oblate
spheroidal molecular shape.
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Experimental Details
Measurements were made at 200C on the C5 triple-axis spectrometer, operated in a two-axis mode, at
the NRU reactor, Chalk River. The reactor spectrum was filtered by 25 cm of polycrystalline beryllium
and a graphite monochromator used to obtain a monochromatic beam with wavelength, X, of 4.085 A
and a wavelength spread (AX/X) of 0.007. The monochromatic beam was analyzed by a Fermi chopper
and was found to contain <0.1% of higher order contamination. The incident and scattered beams were
collimated by Soller slits with angular divergences of 0.290 and 0.240, respectively. The neutron beam
was 1.25 cm wide and 5 cm high. The sample chamber was quartz glass, wall thickness 1 mm, and the
specimen was 1.5 mm thick. Measurements were made by scanning the scattering angle, 20, in steps of
0.10. A typical scan contained 131 steps and required 30 h running time. Repeat measurements
indicated no specimen deterioration over this period.
Measurements were initially made on a sample containing 4.11 g/liter transferrin in pure D20
Ringer's solution. This solute concentration is in the low concentration limit. It is less than twice the
transferrin concentration in normal blood serum (8) and so little aggregation is expected. The results of a
typical scan are shown in Fig. 1. The coherent scattered neutron intensity relative to the incoherent
background scattering is very low for this transferrin concentration in solutions containing a significant
proportion of H20. Consequently most of the experimental measurements were made with transferrin
concentrations of -40 g/liter. The results of a measurement with 38.42 g/liter in pure D20 Ringer's
solution are shown in Fig. 2. Measurements were also made with a concentration (22.2 g/liter)
intermediate between the high and low values. The dependence of the SANS on the H20/D20 ratio in
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FIGURE 2 Small angle neutron scattering from transferrin (c - 38.42 g/liter) in pure D20 Ringer's
solution. The negative experimental momentum transfers are folded on to the positive axis. The solid line is
the best fit to the data assuming an oblate spheroidal molecule. The dashed line is the best fit assuming a
spherical morecule.
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the Ringer's solution was investigated by measurements at four values of this ratio. Some measurements
were also made on hemoglobin (concentration of 10.5 g/liter) in pure D20 Ringer's solution.
ANALYSIS AND RESULTS
Molecular Shape
If I(Q) is the intensity of coherently scattered neutrons at momentum transfer
Q(- 4ir sin 0/X) for perfect collimation, then the experimental intensity J(Q) can be written
as (9):
J(Q)=Kff{I[(Q-y)2 + z2]I/21Wh(y) W(z)dydZ. (1)
y(z) is the horizontal (vertical) coordinate of a point in the detector aperture in the same units
as Q; Wh, (WJ) are normalized weighting functions that specify the horizontal, (vertical)
resolution functions; K is a scale factor. The function Wh was determined experimentally by
scanning the detector in 20 across the direct beam. The function could be well approximated
by a Gaussian whose width (full width at half maximum [FWHM] = 0.350) agreed well with
that calculated from the known collimations. The function Wv was also assumed to be
Gaussian with a width (FWHM = 3.50) calculated from the spectrometer geometry. In
practice it was found that the correction for finite experimental resolution was always small
(c- 1% in the molecular dimensions). The experimental intensity J(Q) is given by
J(Q) = {[S(Q) - C(Q)J _ [E(Q) - C(Q)]}
- 6[R(Q) - C(Q)] _ [E(Q) - C(Q)]} (2)
S, R, and E are the observed intensities (normalized to constant monitor) of the sample,
Ringer's solution, and empty quartz cell, respectively; ts, tR, and tE are the corresponding
measured transmissions; C is the observed intensity with the incident beam blocked by
cadmium; 6 is the volume fraction of solvent in solution.
The shape of the molecule is derived from the form of the "ideal" scattering function I(Q).
A functional form (not necessarily analytic) is usually assumed for I(Q) and the "best"
scattering function is chosen by least squares fitting to the J(Q). In view of the globular shape
blood proteins are thought to have, we assumed the scattering function to be that appropriate
to randomly oriented ellipsoids of revolution. We write (10):
1(Q) = ir2 [QR(sin2 a + v2 COS2 a)'12] sin a da (3)
(x) 3 (sinx -xcosx)
where the semi-axes of the ellipsoid are R, R, and vR. A computer program was written to
convolute the scattering functions of Eq. 3 with the resolution functions Wh, Wv as described
by Eq. 1. A "least squares" fit was then made to the experimental intensities of Eq. 2. The
adjustable parameters were R, v and the scale factor K. A flat background was also included
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as an adjustable parameter to represent any effects due to multiple scattering or scattering
from small impurity fragments in the transferrin. The program evaluated the triple integral to
calculate J(Q) at 131 values of Q in -5 s on a CDC Cyber 175 computer. This analysis is
analogous to a procedure recently described by Sj6berg (11).
The above analysis assumes a specific shape for the transferrin molecule. However, at small
Q, Guinier (10) has shown that I(Q) is given by
I(Q) = I(0) exp (-Q2R2/3), (4)
where Rg is the radius of gyration of randomly oriented molecules, independent of molecular
shape. This functional form can be substituted into Eq. 1 and a resolution-corrected I(Q) can
then be extracted. A plot of the logarithm of I(Q) vs. Q2 is then a straight line at sufficiently
small Q, and the slope of this line is related to Rg.
For the model calculation using Eq. 3 the variance-weighted least squares fit to the low
transferrin concentration data in pure D20 Ringer's solution resulted in two different minima
in the "goodness of fit," x2. The minimum to which the fitting procedure converged was
dependent on whether the anisotropy, v, was initially chosen to be greater (prolate spheroid)
or less (oblate spheroid) than unity. Typical results of the fitting procedure are given in Table
I. The best fit was obtained for an oblate spheroid and the line in Fig. 1 is the experimental
SANS intensity calculated with values given in the upper part of Table I. However, this fit is
only marginally better than that for a prolate spheroid. If the anisotropy is fixed at unity the
spheroid degenerates into a sphere and the fitted J(Q) with this assumption shows somewhat
poorer agreement with the experimental results in the "wings" of the SANS distribution.
The Rg analysis (Eq. 4) results in the fit shown in Fig. 3. As shown by Moore et al. (12) the
straight line obtained from such a plot has a slope a, which is related to the radius of gyration
Rg, by the equation:
Rg = 0.4183X1=a. (5)
The variance weighted least squares analysis yielded Rg = 30.25 ± 0.49 A with a X of 0.685.
From the model-dependent dimensions in the upper part of Table I, we calculate Rg = 30.31,
32.05, and 27.58 for an oblate spheroid, a prolate spheroid and a sphere, respectively. Thus for
TABLE I
TYPICAL RESULTS OF THE LEAST SQUARES FITTING TO SANS DATA
ON TRANSFERRIN IN PURE D20 RINGER'S SOLUTION
Molecular R
Concentration shape (A) v x
c = 4.11 g/liter Oblate 46.6 ± 1.4 0.34 ± 0.07 0.668
Spheroid
Prolate 27.4 ± 1.0 2.20 ± 0.24 0.688
Spheroid
Sphere 35.6 ± 0.5 1 0.751
c = 38.42 g/liter Oblate 42.2 ± 0.5 0.36 ± 0.03 1.02
Spheroid
Prolate 26.0 ± 0.4 1.98 ± 0.03 1.22
Spheroid
Sphere 32.8 ± 0.3 1 1.81
MARTEL ET AL. Physical Characteristics ofHuman Transferrin 375
2.9
2.7
>- 2.5 - 0
Z 2.3_
ui 0Fw~~~~~~~~
Z 2.1 0
0 .9 00
1.7-
i.5
100 200 300 400
(29)2 X 105 ( radians2 )
FIGURE 3 A Guinier plot of the data shown in Fig. 1. Log I is plotted as in reference 12. The straight line
through the data was obtained by a variance-weighted least squares procedure.
the low concentration solution the oblate spheroid shape is favored by both the Guinier and
model-dependent analyses.
The same molecular shapes were fitted to the experimental SANS from the high
transferrin concentration in pure D20 Ringer's. The results, also given in Table I, are similar
to those for the low concentration data. The best fit is again obtained for the assumption of an
oblate spheroid. The assumption of a prolate spheroid gives a significantly (96% confidence
level) larger value of x, while the assumption of a spherical molecule appears to be even less
probable. Some results of the fitting are shown in Fig. 2. It can be clearly seen that in the
"wings" of the distribution the assumption of a spherical molecule is inadequate. The fitted
curve for a prolate spheroid is intermediate between those shown in Fig. 2 in the high Q range.
It is known that interparticle interference effects occur at small values of Q for high
concentration solutions (2). The smallest Q values in our measurements are on the border at
which such effects are expected in transferrin, and the experimental intensities at the smallest
Q values may be depressed because of this. Consequently, the fit to the spherical shape at
small Q may be even worse than Fig. 2 indicates. The lower values of R for the high
transferrin concentration (Table I) are probably due to these interference effects. By utilising
R and v found for the intermediate transferrin concentration, the values for the infinite
dilution limit were obtained by extrapolation. These agree with the low concentration values
within experimental error. The same trends in the fitting were also observed with the Rg
analysis. The data shown in Fig. 2 were analyzed with Eq. 4 and an Rg of 27.79 ± 0.17 was
obtained with a X of 1.20. From the model-dependent dimensions in the lower half of Table I,
we calculate Rg = 27.54, 28.29, and 25.41 for an oblate spheroid, a prolate spheroid, and a
sphere, respectively. Again the oblate spheroid is favored by both the Guinier and model
calculations.
We analysed our hemoglobin measurements by means of Eqs. 1, 2, and 3 in exactly the
same manner as in the analysis of the transferrin data. The differences between x2 for the
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assumptions of each molecular shape in turn are again small. However, in contrast to the
result for transferrin, a prolate spheroidal shape is marginally favored for hemoglobin. The
results for the assumption of an oblate spheroid are: R = 33.9 ± 1.2 A, v = 0.54 ± 0.10 with
X = 0.936. Assuming a prolate spheroidal shape gives R = 23.4 + 10 A, v = 1.75 ± 0.17 with
X = 0.925, while assuming a spherical shape (v -1) gives R = 28.8 ± 0.3 A with x = 0.963.
Schelten et al. (2), using small angle scattering methods, determined a radius of gyration for
hemoglobin of 23.7 ± 0.5. The Rg analysis of our hemoglobin results yields a value for Rg of
23.79 ± .27 A with a X of 0.923. The Rgs calculated from the fitted dimensions of the model
shapes are 22.95, 23.55, and 22.31 for the oblate, prolate, and spherical models, respectively.
Consequently the Rg analysis also indicates a prolate spheroidal shape for hemoglobin in
water. The x-ray diffraction measurements of Muirhead and Perutz (1) indicated that
hemoglobin was spheroidal with semi-axes of 25, 27.5, and 34.5 A. The prolate spheroidal
shape favored by our measurements is in good agreement with the molecular shape suggested
by Muirhead and Perutz, although our analysis indicates the hemoglobin molecule in solution
to be rather more elongated than that indicated by the x-ray diffraction results.
Molecular Weight and Volume
It can be shown (e.g., Yeager [13]) that the scattered intensity at zero momentum transfer,
Ii(0), is given by
Ii(0) = KC1(p1 - p)2 V2 M1/N. (6)
Ci is the weight concentration of solute molecules of species i; pi(ps) is the neutron scattering
density of the solute (solvent) molecules; Vi is the partial specific volume of the solute
molecule; Mi is the molecular weight of the solute molecule; N is Avogadro's number and K a
constant depending on instrumental factors. If I,(0) is measured for a "standard" molecule
with the same p as transferrin then the molecular weight of transferrin (MT) can be
determined relative to that (MS) of the standard.
MT IT(O)CSVS
MS IS(0) CT VT
Since the blood proteins transferrin and hemoglobin are of similar volume, V, they will have
similar scattering densities if the sums of their coherent neutron scattering lengths, Xi ai, are
similar. For a given molecule, a plot of [I(0)/Ci]'/2 vs. the D20 concentration in D20/H20
mixtures, will give the contrast match point (2). Fig. 4 shows this plot for transferrin and gives
the contrast match point as 40.5 ± 0.5% D20. The same value was found for hemoglobin (2).
If there were no exchange this contrast match point would uniquely determine p,. If exchange
takes place, then pi (= 2i ai/ V) is modified because some of the deuteriums from solution
have replaced hydrogens. However, if the concentration dependence of the exchange is the
same for two different molecules in dilute solution and if their pi is the same at one
concentration, then their p, is the same at all concentrations.
A comparison of the amino acid compositions of transferrin (6, 8) and hemoglobin (14)
shows that both molecules have similar amino acid abundances. Carbohydrates are also
present in transferrin, but the percentage is small (-6%). Furthermore, for pH -7, the
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FIGURE 4 The square root of the concentration-normalized intensity at Q = 0 vs. the percentage of D20
in the Ringer's solution. The intensity vanishes for 40.5 ± 0.5% D20.
calculated number of exchangeable hydrogens is similar for transferrin and hemoglobin. For
hemoglobin it is 950 (2) and for transferrin, including carbohydrates and assuming a nominal
molecular weight of -75,000 (7), it is -1,050. If we normalize the value of [I(O)/c]'12 for
transferrin in pure H20 to the corresponding value for hemoglobin (2) we find that the lines
representing [I(O)/C] 12 vs. D20 concentration for transferrin and hemoglobin are identical
within experimental error. Consequently the concentration dependence of exchange is similar
for transferrin and hemoglobin. Since the contrast match points for the two molecules are also
equal, then pi for the molecules are equal at all D20 concentrations.
The partial specific volumes of transferrin and hemoglobin are known (8, 16), and we can
use Eq. 7 to determine the molecular weight, MT, of transferrin relative to that of hemoglobin.
The values IT(O) and Is(O) are determined from the Guinier analysis of our data and the
molecular weight of hemoglobin is taken to be 64,500 (1). After correcting this value for
exchange, the molecular weight of transferrin is then found to be (75 ± 5) x 103, which is in
fair agreement with other recent measurements (7).
It can be shown (e.g., Schelten et al. [2]) that at zero contrast the volume of the solute
molecule, V, is equal to the volume of excluded solvent and is given by
V Eailps.) (8)
where a, is the coherent neutron scattering length of the ith constituent of the solute molecule.
The composition of transferrin in terms of its amino acid and carbohydrate constituents is
known in the form of weight fractions of the transferrin molecular weight (8), (6). Since the
molecular weight of each amino acid and carbohydrate constitutent is known and we have
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determined the molecular weight of transferrin, the number of molecules of each species can
be found. The value of Xi ai can then be evaluated provided exchange is allowed for in the
manner prescribed by Schelten et al. (2). In analogy with these authors we define the
exchange-corrected value of this sum as (2,i ai).,, where
(z a) = ( aai) + 1,050 (aD- aH) CD2O, (9)
where CD20 is the D20 fraction.
Since all our measurements commenced 24 h after mixing, we assume maximum exchange.
Evaluating (2i ai)sol according to Eq. 9 we obtain a value of 2,188 x 10-12 cm for transferrin.
Assuming dilute solutions, the density, Ps, of the scattering lengths of the solvent is given by
Ps = PH2O + (PD20 - PH2o) CD2O = 2.24 x 1010 cm-2. If 2:, ai in Eq. 8 is replaced by (2i ai),41
from above, then V is found to be (98 ± 10) x I03 A3, where the error is estimated from
uncertainties in the molecular weight, the deuteration, and the composition.
DISCUSSION
The present measurements have shown the transferrin molecule to be an oblate spheroid of
revolution with semi-axis of 46.6, 46.6, and 15.8 A. The volume of this oblate spheroid is
(144 ± 45) x I03 A3. From the zero-contrast point the shape-independent volume of'
transferrin is (98 ± 10) x 103 A3. In the case of hemoglobin our measurements suggest the
molecular shape is a prolate spheroid with a volume of 94 x 103 A. From the semi-axes quoted
by Muirhead and Perutz (1) the spheroidal volume of hemoglobin is 99 x 103 A. However, the
shape independent volume determined by Schelten et al. (2) is 83 x 103 A3.
The shape independent volume is the smallest one which can be measured for a molecule. It
is the volume which is inaccessible to the solvent. We see that for both transferrin and
hemoglobin the shape independent volume is indeed smaller than that of the corresponding
spheroid. For hemoglobin a large groove is known to separate the two A-chain components and
this is probably the cause of the difference in the volumes. In the case of transferrin it seems
reasonable to assume that a part of the difference between the two volumes is caused by a
similar effect. However, in view of the rather large experimental errors we cannot be more
specific about the molecular shape.
The molecular weight of transferrin is determined by the present measurement to be 75 ±
5 x 103. Roberts et al. (5) obtained values lying between 73,200 and 76,000, which were
significantly smaller than the then accepted value of 90,000. Palmour and Sutton (6)
subsequently reported a value of 76,000 and more recently Lambin (7) quoted values ranging
from 65,000 to 76,000. These measurements were all made by classical sedimentation or
diffusion methods and the determination reported in the present paper is the first by a
microscopic technique.
A dielectric molecule such as transferrin will be susceptible to electric fields generated in its
environment by, for example, polar membranes. According to Landau and Lifschitz (17), if a
dielectric spheroid is subjected to a uniform electric field, a torque will then be applied to the
spheroid, tending to turn the symmetry axis of an oblate (prolate) spheroid perpendicular
(parallel) to the field. Neglecting rotational diffusion effects, neighboring transferrin and
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hemoglobin molecules in such a field would thus tend to form a particular configuration with
the symmetry axes of the molecules having a definite orientational relationship.
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